As of 2024-12-14, the EV/EBITDA ratio of PureTech Health PLC (PRTC.L) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTC.L's latest enterprise value is 176.10 mil GBP. PRTC.L's TTM EBITDA according to its financial statements is -150.57 mil GBP. Dividing these 2 quantities gives us the above PRTC.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 25.3x | 18.8x |
| Forward P/E multiples | 9.2x - 14.6x | 11.0x |
| Fair Price | (439.95) - (628.42) | (645.28) |
| Upside | -362.5% - -475.0% | -485.0% |
| Date | EV/EBITDA |
| 2024-12-11 | -1.47 |
| 2024-12-10 | -1.48 |
| 2024-12-09 | -1.56 |
| 2024-12-06 | -1.43 |
| 2024-12-05 | -1.41 |
| 2024-12-04 | -1.47 |
| 2024-12-03 | -1.44 |
| 2024-12-02 | -1.45 |
| 2024-11-29 | -1.44 |
| 2024-11-28 | -1.45 |
| 2024-11-27 | -1.49 |
| 2024-11-26 | -1.42 |
| 2024-11-25 | -1.51 |
| 2024-11-22 | -1.53 |
| 2024-11-21 | -1.35 |
| 2024-11-20 | -1.34 |
| 2024-11-19 | -1.35 |
| 2024-11-18 | -1.40 |
| 2024-11-15 | -1.54 |
| 2024-11-14 | -1.58 |
| 2024-11-13 | -1.48 |
| 2024-11-12 | -1.55 |
| 2024-11-11 | -1.49 |
| 2024-11-08 | -1.24 |
| 2024-11-07 | -1.24 |
| 2024-11-06 | -1.26 |
| 2024-11-05 | -1.25 |
| 2024-11-04 | -1.31 |
| 2024-11-01 | -1.21 |
| 2024-10-31 | -1.16 |
| 2024-10-30 | -1.23 |
| 2024-10-29 | -1.21 |
| 2024-10-28 | -1.15 |
| 2024-10-25 | -1.13 |
| 2024-10-24 | -1.19 |
| 2024-10-23 | -1.24 |
| 2024-10-22 | -1.23 |
| 2024-10-21 | -1.20 |
| 2024-10-18 | -1.12 |
| 2024-10-17 | -1.17 |
| 2024-10-16 | -1.19 |
| 2024-10-15 | -1.18 |
| 2024-10-14 | -1.15 |
| 2024-10-11 | -1.14 |
| 2024-10-10 | -1.12 |
| 2024-10-09 | -1.12 |
| 2024-10-08 | -1.11 |
| 2024-10-07 | -1.13 |
| 2024-10-04 | -1.11 |
| 2024-10-03 | -1.02 |